{"slideshow_credits": null, "snippet": "A lawsuit by Allergan says the arrangement by Valeant Pharmaceuticals and William A. Ackman amounts to insider trading, and the judge\u2019s decision will rest upon a set of arcane financial rules.", "abstract": "A lawsuit by Allergan says the arrangement by Valeant Pharmaceuticals and William A. Ackman amounts to insider trading, and the judge\u2019s decision will rest upon a set of arcane financial rules.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "SORKIN", "rank": 1, "firstname": "Andrew", "role": "reported", "organization": "", "middlename": "Ross"}], "original": "By ANDREW ROSS SORKIN"}, "web_url": "http://dealbook.nytimes.com/2014/08/04/valeants-deal-with-ackman-may-be-too-clever-to-be-legal/", "lead_paragraph": null, "headline": {"main": "Ackman and Valeant's Bid for Botox Maker May Be Too Clever to Be Legal", "print_headline": "Perhaps Too Clever to Be Legal", "kicker": "DealBook"}, "_id": "53e02f1138f0d815a9142231", "word_count": "1178", "multimedia": [{"height": 126, "url": "images/2014/08/11/business/Sorkin/Sorkin-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/08/11/business/Sorkin/Sorkin-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/08/11/business/Sorkin/Sorkin-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2014/08/11/business/Sorkin/Sorkin-articleLarge-v2.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/08/11/business/Sorkin/Sorkin-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2014/08/11/business/Sorkin/Sorkin-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-08-04T21:09:36Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Allergan Inc", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Insider Trading", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Pershing Square Capital Management", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Ackman, William A", "name": "persons", "is_major": "Y", "rank": "1"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}